Finance

Beta
Lists
ARTV:NASDAQ
Artiva Biotherapeutics Inc
$9.80
+1.03%
(+0.10) 1D
$9.81
+0.10% (+0.010)
Pre-market
Closed: Jul 1, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARTV...
Open
$9.62
High
$9.96
Low
$9.42
Mkt. cap
476.16M
Avg. vol.
651.28K
Volume
130.00
52-wk high
$14.53
52-wk low
$1.53
EPS
-$3.55
Shares outstanding
24.72M
No. of employees
106
Open
$9.62
High
$9.96
Low
$9.42
Mkt. cap
476.16M
Avg. vol.
651.28K
Volume
130.00
52-wk high
$14.53
52-wk low
$1.53
EPS
-$3.55
Shares outstanding
24.72M
No. of employees
106
News stories
From sources across the web
About Artiva Biotherapeutics Inc
CEO-
Employees106
Founded2019
Headquarters-
SectorBiotechnology
Websiteartivabio.com
Analyst ratings
Based on 6 analysts giving stock ratings to ARTV in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for ARTV in the last 3 months.
Highest
Current $9.80
$41.00 (+318.37%)
Average
$35.80 (+265.31%)
Lowest
$23.00 (+134.69%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$35.00
+257.1%
06/08/2026
Gil Blum
Needham
Buy
Reiterated
$41.00
+318.4%
06/08/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
$40.00
+308.2%
05/25/2026
Unknown Analyst
Jefferies
Buy
Maintained
$23.00
+134.7%
05/21/2026
Martin Fan
Wedbush
Buy
Maintained
$40.00
+308.2%
05/21/2026
David Nierengarten
Wedbush
Buy
Maintained
$40.00
+308.2%
05/21/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
05/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17.86M
17.63M
16.99M
19.31M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.95M
5.26M
4.94M
5.12M
Operating expense
22.81M
22.90M
21.93M
24.43M
Total operating expenses
22.81M
22.90M
21.93M
24.43M
Operating income
-22.81M
-22.90M
-21.93M
-24.43M
Other non operating income
-5.00K
-3.00K
-1.88M
2.00K
EBT including unusual items
-21.25M
-21.53M
-20.77M
-23.52M
EBT excluding unusual items
-21.25M
-21.53M
-22.65M
-23.52M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21.25M
-21.53M
-20.77M
-23.52M
Net profit margin
-
-
-
-
Earnings per share
-0.87
-0.88
-0.84
-0.95
Interest and investment income
1.56M
1.37M
1.16M
912.00K
Interest expense
-
-
-
-
Net interest expenses
1.56M
1.37M
1.16M
912.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.17M
-22.24M
-21.27M
-23.76M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer